Search clinical trials for: LXI-15029 Exemestane

Total 503 results

Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

A Phase I Study of LuoXin Innovate (LXI-15028) in Healthy Chinese Subjects to Evaluate the Pharmacokinetics, Safety and Tolerability.

Healthy

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Unknown

A Study of LXI-15029 in Patients With Advanced Malignant Solid Tumors

Advanced Breast Cancer

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks

Non-erosive Reflux Disease

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Mass Balance and Biotransformation Study of [14C]LXI-15028 in Humans

Healthy Subjects | Pharmacokinetics of 14C-labeled of LXI-15028

China
TC Erciyes University
The Scientific and Technological Research Council of Turkey

Completed

Effect of Food Insulin Index on Metabolic Parameters in Obese Adolescents

Pediatric Obesity
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis

Erosive Esophagitis (EE)

China
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Completed

Efficacy and Safety of LXI-15028 Comparing With Lansoprazole in the Treatment of Duodenal Ulcer

Duodenal Ulcer

China
Merck Sharp & Dohme LLC

Completed

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mild to Moderate Asthma

Asthma

United States, Australia, New Zealand, South Africa
Merck Sharp & Dohme LLC

Completed

A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)

Asthma
Shanghai Fosun Pharmaceutical Industrial Development...

Active, not recruiting

Phase 1 Study of FS-1502 in Patients With HER2 Expressed Advanced Solid Tumors and Breast Cancer.

Breast Cancer | Solid Tumor

China
Orum Therapeutics USA, Inc.

Recruiting

Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors

HER2-positive Breast Cancer | HER-2 Gene Amplification | HER2 Gene Mutation | HER-2 Protein Overexpression

United States
Actavis Inc.

Withdrawn

Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects

Healthy

South Africa
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations

Breast Cancer Metastatic

China
Bayer

Completed

Wellnara Post-marketing Surveillance in Japan (WELLNARA)

Osteoporosis, Postmenopausal

Japan
Lantheus Medical Imaging

Withdrawn

Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing (LMI1195-201)

Heart Failure

United States
Affiliated Hospital to Academy of Military Medical...
Shanghai 10th People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University and other collaborators

Completed

Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy

Gastritis | Atrophic Gastritis | Helicobacter Pylori Associated Gastritis

China
Gainesville Eye Associates
Science in Vision

Completed

Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes

Cataract

United States
Lantheus Medical Imaging

Completed

A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure

Heart Failure

United States
Jules Bordet Institute
Novartis

Completed

Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women (PEARL)

Breast Cancer

Belgium
Affiliated Hospital to Academy of Military Medical...

Unknown

Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions

Gastric Disease

China
Ruijin Hospital

Recruiting

Axi-cel Retreatment in Relapsed/Refractory LBCL

CAR-T Retreatment

China
RXi Pharmaceuticals, Corp.

Unknown

Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD

Age-related Macular Degeneration | Subfoveal Choroidal Neovascularization | Subretinal Scarring | Subretinal Fibrosis

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating LXR-623 in Healthy Japanese Adults

Healthy

Japan
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating LXR-623 in Healthy Subjects

Healthy

United States
TC Erciyes University

Completed

Effect of Kefir on Appetite

Appetitive Behavior

Turkey
BeiGene

Recruiting

BGB-15025 Alone and in Combination With Anti-PD-1 Monoclonal Antibody Tislelizumab in Participants With Advanced Solid Tumors

Advanced Solid Tumor

China, United States, Australia, New Zealand, Korea, Republic of
Changhai Hospital
Guilin Medical University, China; Shanxi Province Cancer Hospital; First People... and other collaborators

Unknown

Application of Linked Color Imaging（LCI） in Diagnosis of Early Gastric Cancer(EGC)

Early Gastric Cancer

China
RXi Pharmaceuticals, Corp.

Unknown

A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Revised Hypertrophic Scars

Hypertrophic Scar

United States, Honduras
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluation LXR-623 in Healthy Adults

Healthy Subjects
Ionis Pharmaceuticals, Inc.
Bayer

Completed

A Study of Safety, PK, & PD of ISIS 416858 Administered Subcutaneously to Patients With End-Stage Renal Disease on Hemodialysis

End-stage Renal Disease (ESRD)

Canada
Pfizer

Terminated

Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients

Early Breast Cancer
Pfizer

Completed

Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST) (FAST)

Post Menopausal Women With Early Breast Cancer
Bayer

Completed

Effects of Wellnara on Climacteric Symptoms

Postmenopause

Germany
SQ Innovation, Inc.
Community Clinical Research Network

Completed

An Open-label, Non Significant Risk, Adhesive Wear Validation Study for the On Body Drug Delivery Device Component of the SQIN-01 Furosemide Infusor (Infusor Device)

Healthy Volunteer Study

United States
RXi Pharmaceuticals, Corp.

Completed

Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109

Cicatrix | Scar Prevention
Affiliated Hospital to Academy of Military Medical...

Unknown

Linked Color Imaging/Magnifying Blue Laser Imaging vs. White Light for Adenomas and Serrated Lesions in Proximal Colon

Colon Cancer

China
Ionis Pharmaceuticals, Inc.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers

Healthy Participants

Canada
National Jewish Health

Completed

Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease (LCI)

Bronchiolitis | Dyspnea | Pneumonitis

United States
Duke University
National Cancer Institute (NCI); Jacobi Medical Center

Completed

Coherence Imaging of the Cervical Epithelium With Scanning a/LCI

Cervical Dysplasia

United States
RXi Pharmaceuticals, Corp.

Completed

A Study to Evaluate the Effectiveness and Safety of RXI 109 on the Outcome of Scar Revision Surgery in Healthy Adults

Hypertrophic Scar

United States, Honduras
RXi Pharmaceuticals, Corp.

Completed

A Study to Evaluate the Effectiveness and Safety of RXI-109 on the Outcome of Keloid Excision Surgery in Healthy Adults

Keloid

United States, Dominican Republic
RXi Pharmaceuticals, Corp.

Completed

Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109

Cicatrix | Scar Prevention

United States
University Medical Center Groningen
Stichting Hemato-Oncologie voor Volwassenen Nederland

Recruiting

Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL (HOVON161)

NHL | DLBCL - Diffuse Large B Cell Lymphoma

Netherlands
National Jewish Health

Active, not recruiting

Utility of Lung Clearance Index Score as a Noninvasive Marker of Small Airways Disease

Chronic Lung Disease

United States
Sirnaomics

Recruiting

Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects

FXI

United States, Canada
Bristol-Myers Squibb

Completed

Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer

Breast Cancer

Czech Republic, United States, Spain, United Kingdom, Ireland, Poland, France, Sweden
Otsuka Pharmaceutical Co., Ltd.

Withdrawn

A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia

Schizophrenia
Veru Inc.

Withdrawn

Efficacy Evaluation of Sabizabulin Monotherapy Versus Active Control for Treatment of ER+HER2- Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy

Epilepsy

United Kingdom
University of Roma La Sapienza

Completed

TXI for the Recognition of Adenomas in Colonoscopy (TRACK)

Colorectal Polyp

Italy

3

Subscribe